Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the clinical launch of its Immune Profile Score (IPS) ...
Questions about sexual orientation, gender identity and changes to queries about race and ethnicity are on track to be asked in the most comprehensive survey of American life by 2027, U.S. Census ...